SND holds online signing ceremonies for new projects

Suzhou New District in East China's Jiangsu province held online signing ceremonies for a batch of new projects on April 22, local media outlets reported.

The projects mainly involve biopharmaceuticals, medical apparatus, high-end equipment manufacturing, and investment funds.

Bain Capital, a leading global fund management company founded in 1984 in the United States, is planning to build a biopharmaceuticals headquarters in SND with a registered capital of $50 million and plans to develop it into the top central nervous biological pharmaceutical company in China.

NRL Capital, which has established close connections with SND in recent years, plans to launch a new round of RMB direct investment funds with a scale of 3 billion yuan ($461.4 million), covering the district's key industries such as medical treatment and health, new-generation infrastructure, new-generation manufacturing, and industrial internet.

Wuhuan Tech, which has been headquartered in Beijing since 2007 with a focus on high-end laser precision measurement technology, plans to invest at least 465 million yuan in the research and development headquarters of anti-terrorism equipment in SND.

WDM Esaote (Suzhou) Medical Technology Co is jointly funded by the renowned Beijing-based medical brand WDM and the Italian medical diagnosis giant Esaote. It plans to invest in a new R&D and manufacturing base for medical imaging equipment, in an effort to realize collaborative innovation and development between its medical centers in Beijing and Suzhou.